XML 130 R120.htm IDEA: XBRL DOCUMENT v2.4.0.6
Capitalization (Details 3) (USD $)
Dec. 31, 2011
FE
 
Outstanding PCRBs for the next three years  
2012 $ 1,605,000,000
2013 1,314,000,000
2014 878,000,000
2015 1,638,000,000
2016 1,050,000,000
FE | PCRB [Member]
 
Outstanding PCRBs for the next three years  
2012 901,000,000
2013 235,000,000
2014 26,000,000
2015 313,000,000
2016 170,000,000
FES
 
Outstanding PCRBs for the next three years  
2012 896,000,000
2013 310,000,000
2014 125,000,000
2015 762,000,000
2016 191,000,000
FES | PCRB [Member]
 
Outstanding PCRBs for the next three years  
2012 828,000,000
2013 235,000,000
2014 26,000,000
2015 313,000,000
2016 170,000,000
Met-Ed
 
Outstanding PCRBs for the next three years  
2012 29,000,000
2013 150,000,000
2014 250,000,000
2015 0
2016 0
Met-Ed | PCRB [Member]
 
Outstanding PCRBs for the next three years  
2012 28,000,000
2013 0
2014 0
2015 0
2016 0
Penelec
 
Outstanding PCRBs for the next three years  
2012 45,000,000
2013 0
2014 150,000,000
2015 0
2016 0
Penelec | PCRB [Member]
 
Outstanding PCRBs for the next three years  
2012 45,000,000
2013 0
2014 0
2015 0
2016 $ 0